These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 334799)

  • 1. Chemotactic factor inactivators of human granulocytes.
    Brozna JP; Senior RM; Kreutzer DL; Ward PA
    J Clin Invest; 1977 Dec; 60(6):1280-8. PubMed ID: 334799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
    Orr FW; Varani J; Kreutzer DL; Senior RM; Ward PA
    Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
    Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
    Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
    Gibson TL; Cohen P
    Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.
    Janusz MJ; Doherty NS
    J Immunol; 1991 Jun; 146(11):3922-8. PubMed ID: 2033261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of biologically active, complement-(C5) derived peptides by cathepsin H.
    Perez HD; Ohtani O; Banda D; Ong R; Fukuyama K; Goldstein IM
    J Immunol; 1983 Jul; 131(1):397-402. PubMed ID: 6408181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte elastase and cathepsin G inactivate factor VII by limited proteolysis.
    Anderssen T; Halvorsen H; Bajaj SP; Osterud B
    Thromb Haemost; 1993 Sep; 70(3):414-7. PubMed ID: 8259540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
    Perez HD; Lipton M; Goldstein IM
    J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced release of oxygen metabolites by monocyte-derived macrophages exposed to proteolytic enzymes: activity of neutrophil elastase and cathepsin G.
    Speer CP; Pabst MJ; Hedegaard HB; Rest RF; Johnston RB
    J Immunol; 1984 Oct; 133(4):2151-6. PubMed ID: 6088632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural changes of the skin induced by human leukocyte elastase and cathepsin G.
    Glinski W; Kuligowski M; Pierozynska-Dubowska M; Glinska-Ferenz M; Jablonska S
    Acta Derm Venereol; 1991; 71(4):277-82. PubMed ID: 1681641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of lysosomal elastase in the digestion of Escherichia coli proteins by human polymorphonuclear leukocytes: experiments with living leukocytes.
    Blondin J; Janoff A
    J Clin Invest; 1976 Oct; 58(4):971-9. PubMed ID: 787011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of chemotactic factor inactivator in modulating alveolar macrophage-derived neutrophil chemotactic activity.
    Robbins RA; Justice JM; Rasmussen JK; Russ WD; Thomas KR; Rennard SI
    J Lab Clin Med; 1987 Feb; 109(2):164-70. PubMed ID: 3805869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Various properties of cathepsin G and elastase from swine peripheral blood neutrophils].
    Kraeva LN; Kokriakov VN; Chesnokov IN; Iakovleva MF; Lyzlova SN
    Biokhimiia; 1988 Apr; 53(4):655-62. PubMed ID: 3395645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin G in human mononuclear phagocytes: comparisons between monocytes and U937 monocyte-like cells.
    Senior RM; Campbell EJ
    J Immunol; 1984 May; 132(5):2547-51. PubMed ID: 6562154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of E. faecalis on the release of serine proteases elastase and cathepsin G, and collagenase-2 (MMP-8) by human polymorphonuclear leukocytes (PMNs).
    Reynaud af Geijersstam A; Sorsa T; Stackelberg S; Tervahartiala T; Haapasalo M
    Int Endod J; 2005 Sep; 38(9):667-77. PubMed ID: 16104981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of leukocyte proteinases on tissue factor pathway inhibitor.
    Petersen LC; Bjørn SE; Nordfang O
    Thromb Haemost; 1992 May; 67(5):537-41. PubMed ID: 1519213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease-modulation of neutrophil superoxide response.
    Kusner DJ; King CH
    J Immunol; 1989 Sep; 143(5):1696-702. PubMed ID: 2547873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
    Schechter NM; Irani AM; Sprows JL; Abernethy J; Wintroub B; Schwartz LB
    J Immunol; 1990 Oct; 145(8):2652-61. PubMed ID: 2212656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the mobilities of granulocytes and the chemotactic factor production by human mononuclear cells (author's transl)].
    Nakayama M
    Hokkaido Igaku Zasshi; 1981 Mar; 56(2):217-31. PubMed ID: 7327510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of chemotactic factors on erythrophagocytosis by human neutrophils.
    Musson RA; Becker EL
    J Immunol; 1976 Aug; 117(2):433-9. PubMed ID: 781130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.